Latest News and Press Releases
Want to stay updated on the latest news?
-
BETHLEHEM, Pa., Aug. 16, 2012 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR), the market leader in oral fluid diagnostics, today announced its enthusiastic support for the expanded...
-
BETHLEHEM, Pa., Aug. 8, 2012 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at...
-
BETHLEHEM, Pa., Aug. 7, 2012 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR), a market leader in oral fluid diagnostics, today announced its consolidated financial results for the second...
-
BETHLEHEM, Pa., July 26, 2012 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR), the market leader in oral fluid diagnostics, today announced its support of numerous rapid hepatitis C (HCV)...
-
2012 Second Quarter Earnings Conference Call Tuesday, August 7, 2012, 5:00 p.m. ET BETHLEHEM, Pa., July 25, 2012 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) has scheduled its...
-
BETHLEHEM, Pa., July 16, 2012 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced the closing of its previously announced public offering of common stock. As a result, the...
-
BETHLEHEM, Pa., July 10, 2012 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced the pricing of an underwritten offering of 6,100,000 shares of its common stock at a price of...
-
BETHLEHEM, Pa., July 9, 2012 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced it has commenced an underwritten public offering of its common stock in an amount of up to...
-
BETHLEHEM, Pa., July 9, 2012 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the...
-
BETHLEHEM, Pa., July 3, 2012 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that it will hold a conference call covering the recent U.S. Food and Drug Administration...